Samuel Horr is a Cardiology physician affiliated with Centennial Medical Center. OpenAlex indexes 35 publications with 1,277 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2400 Patterson St Ste 502
Nashville, TN 37203
Telephone
615-515-1900Registry record last updated 20 Aug 2018.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Inquis Medical, Inc.Program year202518 payments$26,882openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year202521 payments$19,413openpaymentsdata.cms.gov ↗
- Stryker CorporationProgram year202512 payments$16,464openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70%Statin18.8%Atorvastatin Calcium83%Rosuvastatin Calcium17%Part D<11 patientsBeta blocker16.3%Metoprolol Succinate58%Carvedilol42%Part D≥27 patients+ 8 more classes in this area
Blood & clotting
27.2%Factor Xa inhibitor13.8%Eliquis69%Xarelto31%Part D<11 patientsP2Y12 inhibitor10.5%Clopidogrel100%Part D≥32 patients+ 1 more class in this area
Anti-infectives
2.8%Penicillins with extended spectrum2.8%Amoxicillin100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluation of Catheter-Directed Thrombolysis Device Type and Dosing on Treatment Outcomes in Intermediate-Risk Pulmonary Embolism: A PEERLESS Randomized Controlled Trial Post Hoc Analysis
Journal of Vascular and Interventional Radiology
2025 - Novel Aspiration Thrombectomy and Blood Reinfusion System for Acute Intermediate-Risk Pulmonary Embolism: AVENTUS Trial Results
Journal of the Society for Cardiovascular Angiography & Interventions
2025 - OR1-5 | Predictors of Clinical Deterioration and Bailout Following Catheter-Directed Intervention for Intermediate-Risk Pulmonary Embolism: Analysis of the PEERLESS Trial
Journal of the Society for Cardiovascular Angiography & Interventions
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Arthur Ulm, MD
Centennial Medical Center
Mark Womack, MD
Centennial Medical Center
Terri Jerkins, MD
Centennial Medical Center
Sydney Hester, MD
Centennial Medical Center
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”